As I wrote in Issue 052, Hinge CEO and co-founder Daniel Perez predicted that during the coronavirus pandemic:
“Health plans and employers want a trusted solution in times of uncertainty. My prediction (from the eye of the storm) is that over the next six months we’re going to see the most trusted solutions (Livongo, Hinge Health, Teladoc) continue to outperform their peers, and gain even more market share.”
I was impressed by his sleight-of-hand — sandwiching his startup in between two of the only publicly traded digital health companies! — but it did get me thinking a bit more about Hinge’s competition.
There’s a strong likelihood that by the end of 2020, Hinge’s main competitors will be Livongo and Omada Health.
Read More: https://exitsandoutcomes.com/why-omada-health-should-buy-physera-and-other-msk-ma-digital-health-predictions/
Via: Exits & Outcomes